| ◆英語タイトル：Global In Vitro Toxicology Testing Market Size study & Forecast, by Technology (Cell Culture, High Throughput Molecular Imaging, OMICS Technology), By Application (Dermal Toxicity, Endocrine Disruption, Occular Toxicity Others) By End-use (Diagnostics, Chemical Industry, Food Industry, Pharmaceutical Industry, Cosmetic & Household Products, Others ), and Regional Analysis, 2022-2029
|
 | ◆商品コード：BZW23FE0001
◆発行会社（リサーチ会社）：Bizwit Research & Consulting
◆発行日：2023年1月29日
◆ページ数：約200
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
◆産業分野：バイオ
|
◆販売価格オプション
（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
Bizwit Research社の本調査レポートでは、2021年にXX億ドルであった世界のIn Vitro毒性試験市場規模が、2022年から2029年の間にXX%で拡大すると見込んでいます。本書は、In Vitro毒性試験の世界市場を徹底調査しており、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、技術別（細胞培養、ハイスループット、分子画像、オミックス技術）分析、用途別（経皮毒性、内分泌かく乱作用、眼毒性、その他）分析、エンドユーザー別 （診断薬、化学産業、食品産業、製薬産業、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、その他）分析、競争分析、調査プロセスなどを整理しています。また、本書内には、Merck KGaA、Charles River Laboratories 、Bio-Rad Laboratories, Inc.、Abbott、Thermo Fisher Scientific Inc.、Catalent, Inc.、GE Healthcare、Quest Diagnostics Incorporated、Eurofins Scientific、Laboratory Corporation of America Holdingsなどの企業情報が含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界のIn Vitro毒性試験市場規模：技術別
- 細胞培養における市場規模
- ハイスループットにおける市場規模
- 分子画像における市場規模
- オミックス技術における市場規模
・世界のIn Vitro毒性試験市場規模：用途別
- 経皮毒性における市場規模
- 内分泌かく乱作用における市場規模
- 眼毒性における市場規模
- その他における市場規模
・世界のIn Vitro毒性試験市場規模：エンドユーザー別
- 診断薬おける市場規模
- 化学産業における市場規模
- 食品産業における市場規模
- 製薬産業おける市場規模
- その他おける市場規模
・世界のIn Vitro毒性試験市場規模：地域別
- 北米のIn Vitro毒性試験市場規模
- ヨーロッパのIn Vitro毒性試験市場規模
- アジア太平洋のIn Vitro毒性試験市場規模
- 中南米のIn Vitro毒性試験市場規模
- その他地域のIn Vitro毒性試験市場規模
・競争分析
・調査プロセス |
Global In Vitro Toxicology Testing Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. In Vitro Toxicology Testing is used to test hazardous compounds on an organism that has been isolated. It is majorly used to identify or detect the toxicity and effects of harmful chemicals in products such as cosmetics, additives, medications, and so on. It can be used to measure drug absorption, metabolism, excretion, dosage response, threshold response, and so on. The In Vitro Toxicology Testing market is expanding because of factors such as rising government focus on toxicology research, stringent laws, and opposition to animal testing.
According to the CSIR Indian Institute of Toxicology Research in 2020, the Indian government is more aware of the research and development activities in toxicology. It includes government funding and various programs such as In vitro evolution of mRNA cleaving deoxyribozymes: analysis of anticancer activity and modifications of evolved DNAzyme/s for higher efficacy in vitro and in vivo by Dept of Biotechnology, New Delhi. Whereas the rising awareness towards testing across end-user industries and growing technological advancement in bacterial testing are creating lucrative opportunities for the market. However, the lack of in vitro models hampers the market growth in the forecast period.
The key regions considered for the Global In Vitro Toxicology Testing Market study includes Asia Pacific, North America, Europe, Latin America, and the Rest of the World. The Asia Pacific dominated the market in terms of revenue, owing to the rising consumer awareness towards product safety, emergences of CRO, and so on. Whereas the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the rising pharmaceutical drug pipeline and opposition to animal testing which pushes the adoption of other substitutes.
Major market player included in this report are:
Merck KGaA
Charles River Laboratories
Bio-Rad Laboratories, Inc.
Abbott
Thermo Fisher Scientific Inc.
Catalent, Inc.
GE Healthcare
Quest Diagnostics Incorporated
Eurofins Scientific
Laboratory Corporation of America Holdings
Recent Developments in the Market:
In October 2018, SGS SA has launched new in-vitro testing which has the development capabilities of present cells/tissues and flows cytometry mass spectrometry facilities, equipped with high throughput screening, multiplexing technologies, automation and so on.
In August 2019, Abbott signed an agreement with Intoximeters in which Intoximeters received exclusive distribution rights to Abbott’s SoToxa Mobile Test System, a handheld oral fluid solution for drug and alcohol testing in the United States, Methamphetamine, benzodiazepines, amphetamine, cocaine, cannabis (THC), and opiates can all be tested using this product.
Global In Vitro Toxicology Testing Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Technology, Application, End-use, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Cell Culture
High Throughput
Molecular Imaging
OMICS Technology
By Application:
Dermal Toxicity
Endocrine Disruption
Occular Toxicity
Others
By End-use:
Diagnostics
Chemical Industry
Food Industry
Pharmaceutical Industry,
Cosmetic & Household Products,
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. In Vitro Toxicology Testing Market, by Region, 2019-2029 (USD Billion)
1.2.2. In Vitro Toxicology Testing Market, by Technology, 2019-2029 (USD Billion)
1.2.3. In Vitro Toxicology Testing Market, by Application, 2019-2029 (USD Billion)
1.2.4. In Vitro Toxicology Testing Market, by End-use 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global In Vitro Toxicology Testing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global In Vitro Toxicology Testing Market Dynamics
3.1. In Vitro Toxicology Testing Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising government focus on toxicology research
3.1.1.2. Stringent laws and opposition to animal testing
3.1.2. Market Challenges
3.1.2.1. Lack of in vitro models
3.1.3. Market Opportunities
3.1.3.1. Rising awareness towards testing across end-use industries
3.1.3.2. Growing technological advancement in bacterial testing
Chapter 4. Global In Vitro Toxicology Testing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global In Vitro Toxicology Testing Market, by Technology
6.1. Market Snapshot
6.2. Global In Vitro Toxicology Testing Market by Technology, Performance – Potential Analysis
6.3. Global In Vitro Toxicology Testing Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
6.4. In Vitro Toxicology Testing Market, Sub Segment Analysis
6.4.1. Cell Culture
6.4.2. High Throughput
6.4.3. Molecular Imaging
6.4.4. OMICS Technology
Chapter 7. Global In Vitro Toxicology Testing Market, by Application
7.1. Market Snapshot
7.2. Global In Vitro Toxicology Testing Market by Application, Performance – Potential Analysis
7.3. Global In Vitro Toxicology Testing Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. In Vitro Toxicology Testing Market, Sub Segment Analysis
7.4.1. Dermal Toxicity
7.4.2. Endocrine Disruption
7.4.3. Occular Toxicity
7.4.4. Others
Chapter 8. Global In Vitro Toxicology Testing Market, by End-Use
8.1. Market Snapshot
8.2. Global In Vitro Toxicology Testing Market by End-use Performance – Potential Analysis
8.3. Global In Vitro Toxicology Testing Market Estimates & Forecasts by End-Use 2019-2029 (USD Billion)
8.4. In Vitro Toxicology Testing Market, Sub Segment Analysis
8.4.1. Diagnostics
8.4.2. Chemical Industry
8.4.3. Food Industry
8.4.4. Pharmaceutical Industry,
8.4.5. Cosmetic & Household Products,
8.4.6. Others
Chapter 9. Global In Vitro Toxicology Testing Market, Regional Analysis
9.1. In Vitro Toxicology Testing Market, Regional Market Snapshot
9.2. North America In Vitro Toxicology Testing Market
9.2.1. U.S. In Vitro Toxicology Testing Market
9.2.1.1. Test breakdown estimates & forecasts, 2019-2029
9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
9.2.1.3. End-use breakdown estimates & forecasts, 2019-2029
9.2.2. Canada In Vitro Toxicology Testing Market
9.3. Europe In Vitro Toxicology Testing Market Snapshot
9.3.1. U.K. In Vitro Toxicology Testing Market
9.3.2. Germany In Vitro Toxicology Testing Market
9.3.3. France In Vitro Toxicology Testing Market
9.3.4. Spain In Vitro Toxicology Testing Market
9.3.5. Italy In Vitro Toxicology Testing Market
9.3.6. Rest of Europe In Vitro Toxicology Testing Market
9.4. Asia-Pacific In Vitro Toxicology Testing Market Snapshot
9.4.1. China In Vitro Toxicology Testing Market
9.4.2. India In Vitro Toxicology Testing Market
9.4.3. Japan In Vitro Toxicology Testing Market
9.4.4. Australia In Vitro Toxicology Testing Market
9.4.5. South Korea In Vitro Toxicology Testing Market
9.4.6. Rest of Asia Pacific In Vitro Toxicology Testing Market
9.5. Latin America In Vitro Toxicology Testing Market Snapshot
9.5.1. Brazil In Vitro Toxicology Testing Market
9.5.2. Mexico In Vitro Toxicology Testing Market
9.6. Rest of The World In Vitro Toxicology Testing Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Merck KGaA
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Charles River Laboratories
10.2.3. Bio-Rad Laboratories, Inc.
10.2.4. Abbott
10.2.5. Thermo Fisher Scientific Inc.
10.2.6. Catalent, Inc.
10.2.7. GE Healthcare
10.2.8. Quest Diagnostics Incorporated
10.2.9. Eurofins Scientific
10.2.10. Laboratory Corporation of America Holdings
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
❖ 免責事項 ❖http://www.globalresearch.jp/disclaimer